PAPTX Mutual Fund

NAV$10.72

Fund Essentials - as of Jan 31, 2026

Net Assets
$19M
Expense Ratio
2.18%
Dividend Yield (Current)
8.69%
Holdings
1,152
Inception Date
Nov 11, 2022
Fund Family
UBS Asset Management (Americas) LLC
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+3.38%
1 Year+6.88%
3 Year+7.86%

Asset Allocation

Bonds: 47.00%
Cash: 41.84%
Other: 20.35%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
TRVXXState Street Treasury Money Market Portfolio41.84%
-Other Assets In Excess Of Liabilities—18.0%18.00%
SUBFXCarillon Reams Unconstrained Bond Fund5.16%
-Sold CNH Bought USD 202510163.05%
QSPIXAqr Style Premia Alternative Fund1.95%
Top 10 Concentration: 77.68%Report Date: Jan 31, 2026
Download all 1152 holdings for PAPTX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
8.69%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

PAPTX Mutual Fund Overview

PAPTX Mutual Fund (PACE Alternative Strategies Investments Class P2) is managed by UBS Asset Management (Americas) LLC with $18.9M in net assets. PAPTX expense ratio is 2.18%, holding 1152 positions across sectors including Other, Unknown, Communication Services. Inception date: 2022-11-11.

PAPTX performance shows a YTD return of 3.38%. The 1-year return is 6.88%. PAPTX dividend yield stands at 8.69%, paid annually.

PAPTX top holdings include State Street Treasury Money Market Portfolio (41.8%), Other Assets In Excess Of Liabilities—18.0% (18.0%), Carillon Reams Unconstrained Bond Fund (5.2%), Sold CNH Bought USD 20251016 (3.0%), Aqr Style Premia Alternative Fund (1.9%). View all PAPTX holdings, sector breakdown, or dividend history.

PAPTX can be compared against other funds using the overlap calculator or side-by-side comparison tool. PAPTX alternatives are available via the screener, along with tax-loss harvesting opportunities.